A Family With Lead Exposure: Whom to Chelate and When
A family of four lives in a 1920s rental. The father, 38, works at a battery-recycling plant; he has colicky abdominal pain, fatigue, blood lead 55 micrograms/dL, and hemoglobin 10.5 g/dL. The mother, 34, is 22 weeks pregnant and asymptomatic; blood lead 28 micrograms/dL. The 5-year-old has abdominal pain and irritability; blood lead 45 micrograms/dL, hemoglobin 9.8 g/dL. The 2-year-old is asymptomatic; blood lead 12 micrograms/dL. The home has peeling paint and bare soil. The landlord is unresponsive, and the employer offers no relocation.
1. Who needs chelation now, with which agent, and who should not be chelated? Explain by blood lead, symptoms, and pregnancy.
Read the worked answer
Chelate now: the 5-year-old with blood lead 45 micrograms/dL and symptoms - oral dimercaptosuccinic acid (succimer) is reasonable, or CaNa2EDTA if severe or encephalopathic; if encephalopathy or blood lead above 70, add dimercaprol before EDTA. The father with blood lead 55 micrograms/dL and colicky pain should be removed from exposure and treated with CaNa2EDTA; symptoms plus high lead support chelation. Do not chelate routinely: the pregnant mother at 28 micrograms/dL and the asymptomatic 2-year-old at 12 micrograms/dL. In pregnancy, chelation is reserved for severe maternal toxicity because of fetal risk; at 28 micrograms/dL the priority is stopping exposure and expert consultation. The 2-year-old needs exposure control and repeat testing, not chelation.
2. List the immediate nonpharmacologic steps for the family and workplace, including what you would document and report.
Read the worked answer
Immediate steps: remove the father from the battery plant; arrange blood lead testing for all household members; wet-clean surfaces, wash hands and toys, remove shoes, and block access to peeling paint and bare soil; provide lead-safe cleaning and nutrition advice with adequate iron and calcium. Notify public health and, with consent, the employer and landlord in writing. Document the workplace, take-home lead risk, and housing hazard. Do not rely on the landlord's response; involve code enforcement. Report the child's elevated lead level as required.
3. How will you monitor the treated and untreated family members, and what is the fetal risk?
Read the worked answer
Monitoring: after chelation, check blood lead and creatinine, and monitor for rebound 1-2 weeks after a course; repeat until stable. For the untreated child and pregnant mother, repeat blood lead in 2-4 weeks and after remediation. Fetal risk: maternal lead crosses the placenta and can affect neurodevelopment; at 28 micrograms/dL the risk is real but chelation itself carries risk. Coordinate with obstetrics and toxicology, and focus on exposure elimination.